447 related articles for article (PubMed ID: 15740930)
1. Effect of nebivolol on QT dispersion in hypertensive patients with left ventricular hypertrophy.
Galetta F; Franzoni F; Magagna A; Femia FR; Pentimone F; Santoro G; Carpi A
Biomed Pharmacother; 2005; 59(1-2):15-9. PubMed ID: 15740930
[TBL] [Abstract][Full Text] [Related]
2. QT dispersion in elderly athletes with left ventricular hypertrophy.
Galetta F; Franzoni F; Santoro G; Prattichizzo F; Femia FR; Pastine F; Pentimone F
Int J Sports Med; 2003 May; 24(4):233-7. PubMed ID: 12784163
[TBL] [Abstract][Full Text] [Related]
3. Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy.
Galetta F; Franzoni F; Fallahi P; Tocchini L; Graci F; Carpi A; Antonelli A; Santoro G
Biomed Pharmacother; 2010 Oct; 64(8):516-20. PubMed ID: 20044234
[TBL] [Abstract][Full Text] [Related]
4. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
[TBL] [Abstract][Full Text] [Related]
5. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
Saadeh AM; Jones JV
J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
[TBL] [Abstract][Full Text] [Related]
6. [QT dispersion intervals in hypertensives with left ventricular hypertrophy].
Ghanem Wisam MA; Murín J; Jaber J; Radman A; Bulas J; Kozliková K
Vnitr Lek; 2001 Jan; 47(1):20-4. PubMed ID: 15635864
[TBL] [Abstract][Full Text] [Related]
7. [QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes].
Radman A; Murín J; Bulas J; Reptová A; Ravingerová T; Mikes P; Kozliková K; Ghanem W; Jaber J; Baqi L
Vnitr Lek; 2003 Oct; 49(10):802-7. PubMed ID: 14682153
[TBL] [Abstract][Full Text] [Related]
8. Prognostic evaluation of QT-dispersion in elderly hypertensive and normotensive patients.
Dimopoulos S; Nicosia F; Turini D; Zulli R
Pacing Clin Electrophysiol; 2009 Nov; 32(11):1381-7. PubMed ID: 19712075
[TBL] [Abstract][Full Text] [Related]
9. [Temporal QT dispersion in patients with systemic blood hypertension].
Vilas-Boas F; Lima AA; Torreão J; Feitosa GS
Arq Bras Cardiol; 1997 May; 68(5):343-6. PubMed ID: 9497522
[TBL] [Abstract][Full Text] [Related]
10. QT dispersion as a marker of left ventricular mass in essential hypertension.
Maheshwari VD; Girish MP
Indian Heart J; 1998; 50(4):414-7. PubMed ID: 9835201
[TBL] [Abstract][Full Text] [Related]
11. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
[TBL] [Abstract][Full Text] [Related]
12. QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.
Piccirillo G; Germanò G; Quaglione R; Nocco M; Lintas F; Lionetti M; Moisè A; Ragazzo M; Marigliano V; Cacciafesta M
Clin Sci (Lond); 2002 Mar; 102(3):363-71. PubMed ID: 11869178
[TBL] [Abstract][Full Text] [Related]
13. [Left ventricular hypertrophy increases the frequency of ventricular arrhythmia in hypertensive patients].
Ozdemir A; Telli HH; Temizhan A; Altunkeser BB; Ozdemir K; Alpaslan M; Karabağ T
Anadolu Kardiyol Derg; 2002 Dec; 2(4):293-9. PubMed ID: 12460824
[TBL] [Abstract][Full Text] [Related]
14. QT dispersion in essential hypertension.
Clarkson PB; Naas AA; McMahon A; MacLeod C; Struthers AD; MacDonald TM
QJM; 1995 May; 88(5):327-32. PubMed ID: 7796087
[TBL] [Abstract][Full Text] [Related]
15. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.
Fogari R; Zoppi A; Maffioli P; Monti C; Lazzari P; Mugellini A; Derosa G
Diabetes Obes Metab; 2012 Apr; 14(4):341-7. PubMed ID: 22074122
[TBL] [Abstract][Full Text] [Related]
16. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
[TBL] [Abstract][Full Text] [Related]
17. [Dispersion of QT interval in arterial hypertension with left ventricular hypertrophy].
Cavallini B; Perri V; Sali M
Minerva Cardioangiol; 1996; 44(1-2):45-8. PubMed ID: 8767622
[TBL] [Abstract][Full Text] [Related]
18. Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy.
Passino C; Franzoni F; Gabutti A; Poletti R; Galetta F; Emdin M
Int J Cardiol; 2004 Oct; 97(1):57-62. PubMed ID: 15336807
[TBL] [Abstract][Full Text] [Related]
19. Comparison between nebivolol and ramipril in patients with hypertension and left ventricular hypertrophy: a randomized open blinded end-point (PROBE) trial.
Cağlar N; Dincer I
Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1359-68. PubMed ID: 22288296
[TBL] [Abstract][Full Text] [Related]
20. Ventricular arrhythmias in hypertension: in which patients do they occur?
Mayet J; Shahi M; Poulter NR; Sever PS; Thom SA; Foale RA
J Hypertens; 1995 Feb; 13(2):269-76. PubMed ID: 7615959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
